Anlotinib suppresses lung adenocarcinoma growth via inhibiting FASN-mediated lipid metabolism.
Ann Transl Med
; 10(24): 1337, 2022 Dec.
Article
in En
| MEDLINE
| ID: mdl-36660682
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Ann Transl Med
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: